Lilly's Foundayo (orforglipron) weight loss pill gains US FDA approval

Parnell launches first FDA-approved generic florfenicol and flunixin combination for bovine respiratory disease

Abbisko Therapeutics' FGFR4 inhibitor irpagratinib granted orphan designation in Europe for HCC

US FDA approves i-Lumen Scientific's i-SIGHT2 clinical study for dry AMD

Lilly to acquire Centessa Pharmaceuticals for up to USD47 per share

ALK secures EU approval for EURneffy 1 mg as needle-free adrenaline option for children

Sanofi secures EU approval for Rezurock in chronic graft-versus-host disease

Boston Scientific receives FDA clearance for Asurys fluid management system

Aurinia Pharmaceuticals agrees to acquire Kezar Life Sciences

Rocket Pharmaceuticals secures FDA approval for Kresladi gene therapy in severe LAD-I

Pharming receives positive CHMP opinion for Joenja marketing authorisation

Biocytogen partner NEOK Bio secures FDA IND clearance for cancer therapy candidate

Eisai and Nuvation Bio report taletrectinib MAA validated by European regulator

Novo Nordisk's Awiqli once-weekly basal insulin treatment approved by US FDA

Lupin reports tentative FDA approval for Pitolisant Tablets